CVS Health (NYSE:CVS) sheds US$3.0b, company earnings and investor returns have been trending downwards for past three years

Long-term investors in CVS Health Corporation have experienced a 43% decline in share price over three years, falling short of market performance. Recent poor financial results may have caused this. Analyzing EPS trends and shareholder returns can provide insights into investor sentiment and business prospects.